1. The Expanding Field of Biologics in the Management of Chronic Urticaria 
Shyam Joshi, MD, David A. Khan, MD 
The Journal of Allergy and Clinical Immunology: In Practice 
Volume 5, Issue 6, Pages (November 2017)
DOI: /j.jaip
Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2. Figure 1
Mechanisms of action for biotherapeutics currently being used and under investigation for CU.
The Journal of Allergy and Clinical Immunology: In Practice 2017 5, DOI: ( /j.jaip )
Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3. Figure 2
Weekly ISS in the GLACIAL trial with placebo versus omalizumab 300 mg.14 Treatment occurred every 4 weeks for 24 weeks with a 16-week follow-up period.
The Journal of Allergy and Clinical Immunology: In Practice 2017 5, DOI: ( /j.jaip )
Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4. Figure 3
Stepwise treatment diagram for CU. NSAIDs, Nonsterodal anti-inflammatory drugs.
The Journal of Allergy and Clinical Immunology: In Practice 2017 5, DOI: ( /j.jaip )
Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions